Similar articles

• Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

  Tarsy D, Baldessarini RJ. Tarsy D, et al. Neuropharmacology. 1974 Nov;13(10-11):927-40. doi: 10.1016/0028-3908(74)90084-7. Neuropharmacology. 1974. PMID: 4474641 No abstract available.
• The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.

  Dolphin AC, Jenner P, Marsden CD. Dolphin AC, et al. Pharmacol Biochem Behav. 1976 Jun;4(6):661-70. doi: 10.1016/0091-3057(76)90217-3. Pharmacol Biochem Behav. 1976. PMID: 981283
• Rapidly induced dopaminergic supersensitivity: D1/D2 receptor participation and its prevention by an MAO-inhibitor.

  Kleinman A, Tieppo CA, Florez GM, Felicio LF, Nasello AG. Kleinman A, et al. Pharmacol Biochem Behav. 2006 Nov;85(3):592-600. doi: 10.1016/j.pbb.2006.10.014. Epub 2006 Dec 8. Pharmacol Biochem Behav. 2006. PMID: 17157367
• Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.

  Cools AR, van Rossum JM. Cools AR, et al. Life Sci. 1980 Oct 6;27(14):1237-53. doi: 10.1016/0024-3205(80)90217-9. Life Sci. 1980. PMID: 6255271 Review. No abstract available.
• The reserpine receptor.

  Giachetti A, Shore PA. Giachetti A, et al. Life Sci. 1978 Jul 10;23(2):89-92. doi: 10.1016/0024-3205(78)90254-0. Life Sci. 1978. PMID: 355757 Review. No abstract available.